Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.

Urologic oncology - 1 Mar 2015

Bitting Rhonda L, Healy Patrick, Halabi Susan, George Daniel J, Goodin Michael, Armstrong Andrew J

Abstract excerpt

BACKGROUND: The presence of ≥5 circulating tumor cells (CTCs) is prognostic for shorter survival in men with metastatic castration-resistant prostate cancer (mCRPC). However, some men have low CTCs despite widespread disease, suggesting heterogeneity in CTC phenotype or detection. The aim of this study was to evaluate the association of CTC enumeration with clinical disease characteristics and overall survival in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Neoplasm Metastasis

Share to Neoplastic Cells, Circulating

Share to Prognosis

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms, Castration-Resistant

Source

Identifiers

PMID: 25595577
DOI: 10.1016/j.urolonc.2014.09.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.PMID 25595577Read ↗

Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.Semantic proximity Read ↗

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancerSemantic proximity Read ↗

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Semantic proximity Read ↗

Early Dissemination of Circulating Tumor Cells: Biological and Clinical InsightsSemantic proximity Read ↗

Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes.Semantic proximity Read ↗

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.Semantic proximity Read ↗

Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traitsSemantic proximity Read ↗

Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.Semantic proximity Read ↗

Protocol for a Prospective Study Evaluating Circulating Tumour Cells Status to Predict Radical ProstatectomyTreatment Failure in Localised Prostate Cancer Patients (C- ProMeta-1)Semantic proximity Read ↗

Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.Semantic proximity Read ↗

Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by EnzalutamideSemantic proximity Read ↗

Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.